163 related articles for article (PubMed ID: 35490254)
21. Expression of a homeostatic regulator, Wip1 (wild-type p53-induced phosphatase), is temporally induced by c-Jun and p53 in response to UV irradiation.
Song JY; Han HS; Sabapathy K; Lee BM; Yu E; Choi J
J Biol Chem; 2010 Mar; 285(12):9067-76. PubMed ID: 20093361
[TBL] [Abstract][Full Text] [Related]
22. Loss of Wip1 sensitizes cells to stress- and DNA damage-induced apoptosis.
Xia Y; Ongusaha P; Lee SW; Liou YC
J Biol Chem; 2009 Jun; 284(26):17428-37. PubMed ID: 19395378
[TBL] [Abstract][Full Text] [Related]
23. Wip1 sensitizes p53-negative tumors to apoptosis by regulating the Bax/Bcl-xL ratio.
Goloudina AR; Mazur SJ; Appella E; Garrido C; Demidov ON
Cell Cycle; 2012 May; 11(10):1883-7. PubMed ID: 22544321
[TBL] [Abstract][Full Text] [Related]
24. WIP1 phosphatase as a potential therapeutic target in neuroblastoma.
Richter M; Dayaram T; Gilmartin AG; Ganji G; Pemmasani SK; Van Der Key H; Shohet JM; Donehower LA; Kumar R
PLoS One; 2015; 10(2):e0115635. PubMed ID: 25658463
[TBL] [Abstract][Full Text] [Related]
25. Wip1 cooperates with KPNA2 to modulate the cell proliferation and migration of colorectal cancer via a p53-dependent manner.
Wang P; Zhao Y; Liu K; Liu X; Liang J; Zhou H; Wang Z; Zhou Z; Xu N
J Cell Biochem; 2019 Sep; 120(9):15709-15718. PubMed ID: 31127650
[TBL] [Abstract][Full Text] [Related]
26. Expression of Wip1 in kidney carcinoma and its correlation with tumor metastasis and clinical significance.
Sun GG; Wang YD; Liu Q; Hu WN
Pathol Oncol Res; 2015 Jan; 21(1):219-24. PubMed ID: 24970693
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic phosphatase Wip1 is a novel prognostic marker for lung adenocarcinoma patient survival.
Satoh N; Maniwa Y; Bermudez VP; Nishimura K; Nishio W; Yoshimura M; Okita Y; Ohbayashi C; Hurwitz J; Hayashi Y
Cancer Sci; 2011 May; 102(5):1101-6. PubMed ID: 21281403
[TBL] [Abstract][Full Text] [Related]
28. The Wip1 phosphatase and Mdm2: cracking the "Wip" on p53 stability.
Lu X; Nguyen TA; Zhang X; Donehower LA
Cell Cycle; 2008 Jan; 7(2):164-8. PubMed ID: 18333294
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of Wip1 Enhances Sensitivity to Radiation in HeLa Cells Through Activation of p38 MAPK.
Wang HY; Liu ZS; Qiu L; Guo J; Li YF; Zhang J; Wang TJ; Liu XD
Oncol Res; 2014; 22(4):225-233. PubMed ID: 26351212
[TBL] [Abstract][Full Text] [Related]
30. Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer.
Wang L; Mosel AJ; Oakley GG; Peng A
Mol Cancer Ther; 2012 Nov; 11(11):2401-9. PubMed ID: 22973056
[TBL] [Abstract][Full Text] [Related]
31. A novel mathematical model of ATM/p53/NF- κB pathways points to the importance of the DDR switch-off mechanisms.
Jonak K; Kurpas M; Szoltysek K; Janus P; Abramowicz A; Puszynski K
BMC Syst Biol; 2016 Aug; 10(1):75. PubMed ID: 27526774
[TBL] [Abstract][Full Text] [Related]
32. Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.
Clausse V; Goloudina AR; Uyanik B; Kochetkova EY; Richaud S; Fedorova OA; Hammann A; Bardou M; Barlev NA; Garrido C; Demidov ON
Cell Death Dis; 2016 Apr; 7(4):e2195. PubMed ID: 27077811
[TBL] [Abstract][Full Text] [Related]
33. Involvement of dysregulated Wip1 in manganese-induced p53 signaling and neuronal apoptosis.
Ma X; Han J; Wu Q; Liu H; Shi S; Wang C; Wang Y; Xiao J; Zhao J; Jiang J; Wan C
Toxicol Lett; 2015 May; 235(1):17-27. PubMed ID: 25791630
[TBL] [Abstract][Full Text] [Related]
34. A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1.
Wang B; Li D; Sidler C; Rodriguez-Juarez R; Singh N; Heyns M; Ilnytskyy Y; Bronson RT; Kovalchuk O
Oncotarget; 2015 Apr; 6(12):9937-50. PubMed ID: 25888625
[TBL] [Abstract][Full Text] [Related]
35. Wip1 regulates SKOV3 cell apoptosis through the p38 MAPK signaling pathway.
Feng Y; Liu F; Du Z; Zhao D; Cheng J; Guo W
Mol Med Rep; 2017 Jun; 15(6):3651-3657. PubMed ID: 28440479
[TBL] [Abstract][Full Text] [Related]
36. Phosphatase Wip1 controls antigen-independent B-cell development in a p53-dependent manner.
Yi W; Hu X; Chen Z; Liu L; Tian Y; Chen H; Cong YS; Yang F; Zhang L; Rudolph KL; Zhang Z; Zhao Y; Ju Z
Blood; 2015 Jul; 126(5):620-8. PubMed ID: 26012568
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.
Zhang X; Wan G; Mlotshwa S; Vance V; Berger FG; Chen H; Lu X
Cancer Res; 2010 Sep; 70(18):7176-86. PubMed ID: 20668064
[TBL] [Abstract][Full Text] [Related]
38. Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma.
Fuku T; Semba S; Yutori H; Yokozaki H
Pathol Int; 2007 Sep; 57(9):566-71. PubMed ID: 17685927
[TBL] [Abstract][Full Text] [Related]
39. Abrogation of Wip1 expression by RITA-activated p53 potentiates apoptosis induction via activation of ATM and inhibition of HdmX.
Spinnler C; Hedström E; Li H; de Lange J; Nikulenkov F; Teunisse AF; Verlaan-de Vries M; Grinkevich V; Jochemsen AG; Selivanova G
Cell Death Differ; 2011 Nov; 18(11):1736-45. PubMed ID: 21546907
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3.
Pechackova S; Burdova K; Benada J; Kleiblova P; Jenikova G; Macurek L
Oncotarget; 2016 Mar; 7(12):14458-75. PubMed ID: 26883108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
